The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research

The Association Between Short-Acting β < sub > 2 < /sub > -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia
CONCLUSION: Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.PMID:38310584 | PMC:PMC10879376 | DOI:10.1007/s12325-023-02746-0 (Source: Australian Family Physician)
Source: Australian Family Physician - February 4, 2024 Category: Primary Care Authors: David Price Christine Jenkins Kerry Hancock Rebecca Vella Florian Heraud Porsche Le Cheng Ruth Murray Maarten Beekman Sinthia Bosnic-Anticevich Fabio Botini Victoria Carter Angelina Catanzariti Joe Doan Kirsty Fletton Ata Kichkin Thao Le Chantal Le Lievre Source Type: research